Radiomics-based machine learning models to predict progression and biomarker status in non-small cell lung cancer (NSCLC) patients treated with immunotherapy

被引：0
|
作者：
Yu, Jisang
Velichko, Yury
Kim, Hyeonseon
Soliman, Moataz
Gennnaro, Nicolo
Kim, Leeseul
Oh, Youjin
Djunadi, Trie Arni
Lee, Jeeyeon
Chung, Liam Il-Young
Yoon, Sungmi
Shah, Zunairah
Lee, Soowon
Nam, Cecilia
Hong, Timothy
Agrawal, Rishi
Aouad, Pascale
Chae, Young Kwang
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5619
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Using MRI Radiomics to Predict the Efficacy of Immunotherapy for Brain Metastasis in Patients with Non-small Cell Lung Cancer
    Xu, J.
    Wang, P.
    Li, Y.
    Shi, X.
    Yu, J.
    Teng, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E65 - E65
  • [22] Dual-Region Computed Tomography Radiomics-Based Machine Learning Predicts Subcarinal Lymph Node Metastasis in Patients with Non-small Cell Lung Cancer
    Yan, Hao-Ji
    Zhao, Jia-Sheng
    Zuo, Hou-Dong
    Zhang, Jun-Jie
    Deng, Zhi-Qiang
    Yang, Chen
    Luo, Xi
    Wan, Jia-Xin
    Zheng, Xiang-Yun
    Chen, Wei-Yang
    Li, Su-Ping
    Tian, Dong
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5011 - 5020
  • [23] Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer
    Gu, Qianbiao
    Feng, Zhichao
    Liang, Qi
    Li, Meijiao
    Deng, Jiao
    Ma, Mengtian
    Wang, Wei
    Liu, Jianbin
    Liu, Peng
    Rong, Pengfei
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 118 : 32 - 37
  • [24] Clinical-Radiomic Models Predict Overall Survival Among Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Tunali, I.
    Tan, Y.
    Gray, J. E.
    Eschrich, S.
    Guvenis, A.
    Gillies, R.
    Schabath, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1129 - S1129
  • [25] Immunotherapy Beyond Progression for Patients with Advanced Non-Small Cell Lung Cancer
    Ge, X.
    Zhang, Z.
    Yan, X.
    Zhang, F.
    Yuan, F.
    Han, X.
    Huang, Z.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Zhi, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S641 - S642
  • [26] Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
    Ge, Xiangwei
    Zhang, Zhibo
    Zhang, Sujie
    Yuan, Fang
    Zhang, Fan
    Yan, Xiang
    Han, Xiao
    Ma, Junxun
    Wang, Lijie
    Tao, Haitao
    Li, Xiaoyan
    Zhi, Xiaoyu
    Huang, Zhiyue
    Hofman, Paul
    Prelaj, Arsela
    Banna, Giuseppe Luigi
    Mutti, Luciano
    Hu, Yi
    Wang, Jinliang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2391 - 2400
  • [27] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [28] The influence of polypharmacy on outcome in real life non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Bjoernhart, B.
    Hansen, K. H.
    Jorgensen, T. L.
    Herrstedt, J.
    Schytte, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S858 - S858
  • [29] Hypoxia-related radiomics predict checkpoint blockade immunotherapy response of non-small cell lung cancer patients
    Tunali, Ilke
    Tan, Yan
    Gray, Jhanelle E.
    Katsoulakis, Evangelia
    Eschrich, Steven A.
    Saller, James
    Boyle, Theresa
    Qi, Jin
    Guvenis, Albert
    Gillies, Robert J.
    Schabath, Matthew B.
    CANCER RESEARCH, 2020, 80 (16)
  • [30] Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer
    Zhao, Qian
    Li, Butuo
    Xu, Yiyue
    Wang, Shijiang
    Zou, Bing
    Yu, Jinming
    Wang, Linlin
    CANCER MEDICINE, 2021, 10 (18): : 6291 - 6303
12345